UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

Oral Antidiabetes Medication Adherence and Health Care Utilization Among Medicaid-Enrolled Type 2 Diabetic Patients Beginning Monotherapy

Diabetes care, 2008-02, Vol.31 (2), p.e5-e5

2008

Link zum Volltext

Verfügbarkeit prüfen

EGFR mutation testing and TKI treatment patterns among veterans with stage III and IV non-small cell lung cancer

Cancer treatment and research communications, 2021, Vol.27, p.100327-100327, Article 100327

2021

Link zum Volltext

Verfügbarkeit prüfen

Real-world treatment patterns of metastatic non-small cell lung cancer (mNSCLC) patients receiving epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs)

Journal of clinical oncology, 2021-10, Vol.39 (28_suppl), p.289-289

2021

Link zum Volltext

Verfügbarkeit prüfen

Real-world utilization of liquid biopsy for epidermal growth factor receptor (EGFR) testing in patients with metastatic non-small cell lung cancer (mNSCLC)

Journal of clinical oncology, 2022-10, Vol.40 (28_suppl), p.402-402

2022

Link zum Volltext

Verfügbarkeit prüfen

Impact of Oncology Care Model (OCM) on episode costs and performance revenues: Considerations for oncology practices

Journal of clinical oncology, 2018-10, Vol.36 (30_suppl), p.102-102

2018

Link zum Volltext

Verfügbarkeit prüfen

Real-world systemic therapy utilization in Medicare patients with locally advanced or metastatic urothelial carcinoma

Journal of clinical oncology, 2018-02, Vol.36 (6_suppl), p.415-415

2018

Link zum Volltext

Verfügbarkeit prüfen

Incidence of secondary myelodysplastic syndrome and acute myeloid leukemia in patients with ovarian and breast cancer in real-world setting in the U.S

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.5574-5574

2017

Link zum Volltext

Verfügbarkeit prüfen

Real-world outcomes among patients with epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors versus immunotherapy or chemotherapy in first-line setting

Journal of clinical oncology, 2020-10, Vol.38 (29_suppl), p.281-281

2020

Link zum Volltext

Verfügbarkeit prüfen

Economic burden of select adverse events (AEs) in patients (Pts) with advanced urothelial cancer (aUC) treated with first-line (1L) systemic therapy

Journal of clinical oncology, 2019-03, Vol.37 (7_suppl), p.363-363

2019

Link zum Volltext

Verfügbarkeit prüfen

Real-world outcomes among patients with epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors versus immunotherapy or chemotherapy in first-line setting

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e19345-e19345

2020

Link zum Volltext

Verfügbarkeit prüfen

Health resource utilization and costs for stage IV bladder cancer in community oncology settings

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e16032-e16032

2017

Link zum Volltext

Verfügbarkeit prüfen

Treatment patterns and outcomes in metastatic bladder cancer in community oncology settings

Journal of clinical oncology, 2017-02, Vol.35 (6_suppl), p.396-396

2017

Link zum Volltext

Verfügbarkeit prüfen

Real-world effectiveness of fulvestrant monotherapy as first hormonal therapy in metastatic breast cancer patients

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e12537-e12537

2017

Link zum Volltext

Verfügbarkeit prüfen

Adherence to National Comprehensive Cancer Network Guidelines for BRCA testing among breast cancer patients

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e13624-e13624

2018

Link zum Volltext

Verfügbarkeit prüfen

Disease Burden Associated With International Classification of Diseases 9 (ICD-9) Diagnosed Influenza and Related Complications in United States Children Aged 6–35 Months

Open forum infectious diseases, 2016-12, Vol.3 (suppl_1)

2016

Link zum Volltext

Verfügbarkeit prüfen

Prescribing patterns for topical retinoids within NAMCS data

Journal of drugs in dermatology, 2005-03, Vol.4 (2), p.172

2005

Link zum Volltext

Verfügbarkeit prüfen

Outcomes associated with inhaled corticosteroid use in asthma and COPD: an update

Expert review of pharmacoeconomics & outcomes research, 2004-12, Vol.4 (6), p.645-656

2004

Link zum Volltext

Verfügbarkeit prüfen

Effect of availability of oral iron chelation therapy (ICT) on initiation, duration, and dose adequacy in patients with myelodysplastic syndromes (MDS) and transfusional iron overload (TIO)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e17584-e17584

2013

Link zum Volltext

Verfügbarkeit prüfen

How does drug treatment for diabetes compare between Medicare Advantage Prescription Drug Plans ?

Health services research, 2013-06, Vol.48 (3), p.1057

2013

Link zum Volltext

Verfügbarkeit prüfen

Treatment patterns, clinical outcomes, health resource utilization, and cost in patients with BRCA-mutated metastatic breast cancer treated in community oncology settings

Cancer treatment and research communications, 2019, Vol.19, p.100121-100121, Article 100121

2019

Link zum Volltext

Verfügbarkeit prüfen

Medicare Prescription Drug Coverage and Home Use of Erythropoiesis-Stimulating Agents for MDS-Associated Anemia: A Medicare-Database Analysis

Blood, 2012-11, Vol.120 (21), p.3176-3176

2012

Link zum Volltext

Verfügbarkeit prüfen

A Retrospective Cohort Study of the Incidence, Healthcare Resource Utilization, and Costs of ICD-9 Diagnosed Influenza and Related Complications in US Children

The Pediatric infectious disease journal, 2017-07

2017

Link zum Volltext

Verfügbarkeit prüfen

Impact of Exposure to Evidence-Based Pharmacotherapy on Outcomes Following Acute Myocardial Infarction in Older Adults

Journal of the American Geriatrics Society (JAGS), 2012-09, Vol.60 (10), p.1854-1861

2012

Link zum Volltext

Verfügbarkeit prüfen

Use and spending on antineoplastic therapy (AT) in the Medicare population and the role of supplemental coverage

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.6060-6060

2012

Link zum Volltext

Verfügbarkeit prüfen

Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in medicaid-enrolled patients with type 2 diabetes mellitus

Clinical therapeutics, 2007, Vol.29 Spec No, p.1306

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 30

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(27)

Publikationsform

Sprache

Englisch
(30)

Erscheinungsjahr

n.n

Thema

Humans
(6)
Middle Aged
(6)
Female
(5)
Male
(5)
Retrospective Studies
(5)
Adult
(3)
Aged
(3)
Diabetes Mellitus, Type 2 - Drug Therapy
(3)
Behavior Modification
(2)
Benzodiazepines
(2)
Comorbidity
(2)
Diabetes
(2)
Diabetes Mellitus, Type 2 - Economics
(2)
Health Outcomes
(2)
Health-Related Quality Of Life
(2)
Hospitalization - Statistics & Numerical Data
(2)
Hypoglycemic Agents - Therapeutic Use
(2)
Insomnia
(2)
Logistic Models
(2)
Medicaid
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Oral Antidiabetes Medication Adherence and Health Care Utilization Among Medicaid-Enrolled Type 2 Diabetic Patients Beginning Monotherapy

EGFR mutation testing and TKI treatment patterns among veterans with stage III and IV non-small cell lung cancer

Real-world treatment patterns of metastatic non-small cell lung cancer (mNSCLC) patients receiving epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs)

Real-world utilization of liquid biopsy for epidermal growth factor receptor (EGFR) testing in patients with metastatic non-small cell lung cancer (mNSCLC)

Impact of Oncology Care Model (OCM) on episode costs and performance revenues: Considerations for oncology practices

Real-world systemic therapy utilization in Medicare patients with locally advanced or metastatic urothelial carcinoma

Incidence of secondary myelodysplastic syndrome and acute myeloid leukemia in patients with ovarian and breast cancer in real-world setting in the U.S

Real-world outcomes among patients with epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors versus immunotherapy or chemotherapy in first-line setting

Economic burden of select adverse events (AEs) in patients (Pts) with advanced urothelial cancer (aUC) treated with first-line (1L) systemic therapy

Real-world outcomes among patients with epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors versus immunotherapy or chemotherapy in first-line setting

Health resource utilization and costs for stage IV bladder cancer in community oncology settings

Treatment patterns and outcomes in metastatic bladder cancer in community oncology settings

Real-world effectiveness of fulvestrant monotherapy as first hormonal therapy in metastatic breast cancer patients

Adherence to National Comprehensive Cancer Network Guidelines for BRCA testing among breast cancer patients

Disease Burden Associated With International Classification of Diseases 9 (ICD-9) Diagnosed Influenza and Related Complications in United States Children Aged 6–35 Months

Prescribing patterns for topical retinoids within NAMCS data

Outcomes associated with inhaled corticosteroid use in asthma and COPD: an update

Effect of availability of oral iron chelation therapy (ICT) on initiation, duration, and dose adequacy in patients with myelodysplastic syndromes (MDS) and transfusional iron overload (TIO)

How does drug treatment for diabetes compare between Medicare Advantage Prescription Drug Plans ?

Treatment patterns, clinical outcomes, health resource utilization, and cost in patients with BRCA-mutated metastatic breast cancer treated in community oncology settings

Medicare Prescription Drug Coverage and Home Use of Erythropoiesis-Stimulating Agents for MDS-Associated Anemia: A Medicare-Database Analysis

A Retrospective Cohort Study of the Incidence, Healthcare Resource Utilization, and Costs of ICD-9 Diagnosed Influenza and Related Complications in US Children

Impact of Exposure to Evidence-Based Pharmacotherapy on Outcomes Following Acute Myocardial Infarction in Older Adults

Use and spending on antineoplastic therapy (AT) in the Medicare population and the role of supplemental coverage

Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in medicaid-enrolled patients with type 2 diabetes mellitus

Aktive Filter

Suchergebnisse filtern